COVID‐19‐related dermatosis in November 2019: could this case be Italy’s patient zero?
Raffaele Gianotti, Massimo Barberis, Giovanni Fellegara, Cristina Galván‐Casas, E. Gianotti
Abstract
Milan, the largest city in northern Italy, was one of the first European metropolitan areas to be affected by the COVID-19 pandemic. We analyzed skin biopsies of patients from Milan with dermatoses and positive PCR swabs for SARS-CoV-2 at different stages of the infection (1,2). The results were compared to skin biopsies of 20 COVID-19 non-diagnosed patients with dermatoses, who were at high-risk of COVID-19 infection.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPandemicMedicineDermatologySkin biopsyVirologyBiopsyPathologyOutbreakInfectious disease (medical specialty)DiseaseDermatological and COVID-19 studiesSARS-CoV-2 and COVID-19 ResearchAutoimmune and Inflammatory Disorders